BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 09/02/2024

FDA Clears Meloxicam Tablets for Approval

The FDA has determined that the 7.5mg and 15mg meloxicam tablets were not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications.

Source: Federal Register — Food and Drug AdministrationOpen original release →